ReviewEmerging infectious diseases2002
Human campylobacteriosis in developing countries.
Review in Emerging infectious diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
186 citing papers in PubMed, 8 syntheses or guidelines pooled it, 527 citations in OpenAlex.
- Prevalence and determinants of Campylobacter infection in under-five children of East Africa: systematic review and meta-analysis.BMC infectious diseases · 2026Pooled it
- A systematic review of the methodological considerations in Campylobacter burden of disease studies.PLoS neglected tropical diseases · 2025Pooled it
- Pooled it
- Prevalence and associated factor of Campylobacter species among less than 5-year-old children in Ethiopia: a systematic review and meta-analysis.European journal of medical research · 2021Pooled it
- A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries.PloS one · 2021Pooled it
- Prevalence of Campylobacter species in human, animal and food of animal origin and their antimicrobial susceptibility in Ethiopia: a systematic review and meta-analysis.Annals of clinical microbiology and antimicrobials · 2020Pooled it
- Pooled it
- Pooled it
- Phylogenetic analyses and antimicrobial resistance profiles of Campylobacter spp. from diarrhoeal patients and chickens in Botswana.PloS one · 2018Trial
- Occurrence, load and transport-associated risk factors of Salmonella spp. in chickens sold in informal live bird markets in Centre-Nord Region, Burkina Faso.Poultry science · 2026Article
- Prevalence, species diversity, and antimicrobial resistance profiles ofMicrobiology spectrum · 2026Article
- Frequency of Antimicrobial Resistance Among Fecal Bacteria Pathogens in an Informal Settlement in Nairobi, Kenya, 2018 to 2020.Microorganisms · 2026Article
- Spatial and Temporal Patterns ofGeoHealth · 2026Article
- Prevalence, quantification, and household-level risk factors associated with Salmonella spp. infection in chickens in Boussouma commune, Burkina Faso.BMC microbiology · 2026Article
- Specific chromogenic assay for detection of hippuricase-positive bacteria and its validation in raw chicken meat samples.Scientific reports · 2025Article
- Article
- Systematic review and meta-analysis ofOne health (Amsterdam, Netherlands) · 2025Review
- Prevalence, antibiotic resistance, resistance and virulence determinants ofOne health (Amsterdam, Netherlands) · 2025Review
- Optimization ofJournal of environmental engineering (New York, N.Y.) · 2025Article
- MAJOR LIVESTOCK-ASSOCIATED ZOONOSES IN MONGOLIA: AN OVERVIEW.Zoonoses (Shannon, Ireland) · 2025Article
126 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Campylobacteriosis is a collective description for infectious diseases caused by members of the bacterial genus Campylobacter. The only form of campylobacteriosis of major public health importance is Campylobacter enteritis due to C. jejuni and C. coli. Research and control efforts on the disease have been conducted more often in developed countries than developing countries. However, because of the increasing incidence, expanding spectrum of infections, potential of HIV-related deaths due to Campylobacter, and the availability of the complete genome sequence of C. jejuni NCTC 11168, interest in campylobacteriosis research and control in developing countries is growing. We present the distinguishing epidemiologic and clinical features of Campylobacter enteritis in developing countries relative to developed countries. National surveillance programs and international collaborations are needed to address the substantial gaps in the knowledge about the epidemiology of campylobacteriosis in developing countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.